In the Department of Medicine, there were over fifty funded projects from the 2013 academic year.  

Selected studies included:





Rob Sorrentino

Late Sodium Current Blockade in High-Risk ICD Patients


Sheldon Litwin

Morbidity and Mortality Related to Gastric Bypass Surgery





Carlos Isales

Age-Induced Impairment of Nutrient Signaling Results in Bone Loss


Max Stachura

Health Sensor Informatics to Support Sleep Disorders Diagnosis





Satish Rao

Double-Blind, Placebo Controlled Trial Comparing Neomycin to Rifaximin Plus Neomycin in the Treatment of Methane Positive Subjects with Constipation-Predominant Irritable Bowel Syndrome


Satish Rao

Novel Treatment Strategies for Constipation and Role of Brain Gu




General Medicine

Jaspal Gujral

Clarification of Optimal Anticoagulation Through Genetics





Farrukh Awan

Single-Arm, Phase II, Open-Label Study to Determine the Efficacy of 100 mg 2x Daily Oral Dosing of Midostaurin Adm.to Patients with Aggressive Systemic Mastocytosis or Mast Cell Leukemia +/- an Assoc. Hematological Clonal Non-Mast Cell Lineage Disease


Olivier Rixe

An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF with Adjuvant Temozolomide in Patients with Newly Diagnosed, Surgically Resected, EGFRvlll-Positive Glioblastoma (The "ACT IV" Study)




Infectious Diseases

Cheryl Newman

A Phase IIb, Dose Ranging Study of Oral GSK1265744 in Combination with Nucleoside Reverse Transcriptase Inhibitors for Induction of HIV-1 Virologic Suppression followed by an Evaluation of Maintenance of Virologic Suppression when Oral GSK1265744 is Combined with Oral Rilpivirine in HIV-1 Infected Antiretroviral Therapy Naive Adult


Peter Rissing

HIV Early Intervention Services (EIS) Program Existing Geographic Service Areas (EISEGA)





Michael Madaio

The Role of Cell Death in Lupus Nephritis


Tracy McGaha

The Role of Indoleamine 2-3 Dioxygenase in Marginal Zone-Mediated Tolerance





Caralee Forseen

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy (CAT) Regimen of Inhaled Antibiotics for the Treatment of Chronic Pulmonary Pseudomonas aeruginosa Infection in Subjects with Cystic Fibrosis


James Gossage

Brain Vascular Malformation Consortium: Predictors of Clinical Course